Abstract

Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension

Author(s): Allen Loyd V Jr

Issue: May/Jun 2021 - Volume 25, Number 3

Page(s): 234

Download in electronic PDF format for $75
  • Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Page 1

Abstract

A formulation for preparing Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • tacrolimus
  • macrolide antibiotic
  • immunosuppressant
  • immunosuppressive agent
  • immunity
  • organ transplantation
  • stem cell transplantation
  • graft-vs-host disease

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2021
Pg. 234
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 153
Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 416
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 45
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2015
Pg. 333
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Author(s): Allen Loyd V
Nov/Dec 2019
Pg. 491
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 232
Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 419
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 370-377
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
Jan/Feb 2018
Pg. 58
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 328
Tacrolimus 0.1% Topical Microemulsion
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2018
Pg. 51
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 319
Tacrolimus 0.06% Ophthalmic Drops
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 502
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 144
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 141
Tacrolimus 0.5-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr